MC
ANGO icon

Mathes Company’s AngioDynamics ANGO Stock Holding History

Mathes Company’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,175
Closed -$117K – 125
2023
Q2 		$117K Buy
+11,175
New +$108K 0.05% 124
2022
Q4 		$154K Hold
11,175
– – 0.08% 126
2022
Q3 		$229K Hold
11,175
– – 0.13% 112
2022
Q2 		$216K Hold
11,175
– – 0.11% 118
2022
Q1 		$241K Hold
11,175
– – 0.09% 120
2021
Q4 		$308K Buy
+11,175
New +$308K 0.11% 110

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mathes Company's ANGO Position: Q3 2023 in Review

Mathes Company sold out of AngioDynamics (ANGO) in Q3 2023, closing a stake of 11,175 shares — an estimated $117K sold.

Mathes Company first reported a position in ANGO in Q4 2021 and held it in 6 quarters. The position peaked at $308K in Q4 2021. 154 funds tracked by Wall St. Rank hold ANGO as of Q3 2023.

  • Mathes Company reported no remaining AngioDynamics position as of Q3 2023 after selling out during the quarter.
  • Mathes Company sold 11,175 AngioDynamics shares in Q3 2023, an estimated $117K.
  • Mathes Company first reported a position in AngioDynamics in Q4 2021 and held it in 6 quarters.
  • Mathes Company's AngioDynamics position peaked at $308K in Q4 2021.
  • 154 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2023.

Based on Mathes Company's 13F filing for Q3 2023, filed 26 Oct 2023.